Evaluating Exploratory IND Studies according to the Ethical Framework of 21 CFR 50 subpart D Robert “Skip” Nelson, MD PhD Senior Pediatric Ethicist Lead Medical Officer Office of Pediatric Therapeutics, Office of the - Ethicist - Document - PDFSEARCH.IO

First Page		Document Content
Pharmacology Medicine Pharmaceutical sciences Design of experiments Food and Drug Administration Clinical trial Informed consent Informed assent Institutional review board Research Clinical research Medical ethics		Evaluating Exploratory IND Studies according to the Ethical Framework of 21 CFR 50 subpart D Robert “Skip” Nelson, MD PhD Senior Pediatric Ethicist/Lead Medical Officer Office of Pediatric Therapeutics, Office of the Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 175,80 KB Share Document on Facebook

	Human Informed Consent Form Instructions to the Student Researcher(s): An informed consent/assent/permission form should be developed in consultation with the Adult Sponsor, Designated Supervisor or Qualified Scientist. DocID: 1uTGr - View Document
	Human Informed Consent Form Instructions to the Student Researcher(s): An informed consent/assent/permission form should be developed in consultation with the Adult Sponsor, Designated Supervisor or Qualified Scientist. DocID: 1tImY - View Document
	Submit by Email Informed Consent / Assent Checklist Required Elements DocID: 1js7Z - View Document
	Investigator Guidance Series University of Utah Institutional Review Board ASSENT Definitions The principle of respect for persons requires that the choice of an autonomous person be respected. Under the usual DocID: 1agSM - View Document
	Research Ethics Review Committee WHO ERC 20, AVENUE APPIA – CH-1211 GENEVA 27 – SWITZERLAND – HTTP://INTRANET.WHO.INT/HOMES/RPC/ERC – HTTP://WWW.WHO.INT/RPC/RESEARCH_ETHICS The Process of Obtaining Informed Conse DocID: 178YA - View Document